Cargando…

Lysozyme-coated silver nanoparticles for differentiating bacterial strains on the basis of antibacterial activity

Lysozyme, an antibacterial enzyme, was used as a stabilizing ligand for the synthesis of fairly uniform silver nanoparticles adopting various strategies. The synthesized particles were characterized using UV-visible spectroscopy, FTIR, dynamic light scattering (DLS), and TEM to observe their morphol...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashraf, Sumaira, Chatha, Mariyam Asghar, Ejaz, Wardah, Janjua, Hussnain Ahmed, Hussain, Irshad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242785/
https://www.ncbi.nlm.nih.gov/pubmed/25435831
http://dx.doi.org/10.1186/1556-276X-9-565
_version_ 1782346010274562048
author Ashraf, Sumaira
Chatha, Mariyam Asghar
Ejaz, Wardah
Janjua, Hussnain Ahmed
Hussain, Irshad
author_facet Ashraf, Sumaira
Chatha, Mariyam Asghar
Ejaz, Wardah
Janjua, Hussnain Ahmed
Hussain, Irshad
author_sort Ashraf, Sumaira
collection PubMed
description Lysozyme, an antibacterial enzyme, was used as a stabilizing ligand for the synthesis of fairly uniform silver nanoparticles adopting various strategies. The synthesized particles were characterized using UV-visible spectroscopy, FTIR, dynamic light scattering (DLS), and TEM to observe their morphology and surface chemistry. The silver nanoparticles were evaluated for their antimicrobial activity against several bacterial species and various bacterial strains within the same species. The cationic silver nanoparticles were found to be more effective against Pseudomonas aeruginosa 3 compared to other bacterial species/strains investigated. Some of the bacterial strains of the same species showed variable antibacterial activity. The difference in antimicrobial activity of these particles has led to the conclusion that antimicrobial products formed from silver nanoparticles may not be equally effective against all the bacteria. This difference in the antibacterial activity of silver nanoparticles for different bacterial strains from the same species may be due to the genome islands that are acquired through horizontal gene transfer (HGT). These genome islands are expected to possess some genes that may encode enzymes to resist the antimicrobial activity of silver nanoparticles. These silver nanoparticles may thus also be used to differentiate some bacterial strains within the same species due to variable silver resistance of these variants, which may not possible by simple biochemical tests.
format Online
Article
Text
id pubmed-4242785
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-42427852014-11-28 Lysozyme-coated silver nanoparticles for differentiating bacterial strains on the basis of antibacterial activity Ashraf, Sumaira Chatha, Mariyam Asghar Ejaz, Wardah Janjua, Hussnain Ahmed Hussain, Irshad Nanoscale Res Lett Nano Express Lysozyme, an antibacterial enzyme, was used as a stabilizing ligand for the synthesis of fairly uniform silver nanoparticles adopting various strategies. The synthesized particles were characterized using UV-visible spectroscopy, FTIR, dynamic light scattering (DLS), and TEM to observe their morphology and surface chemistry. The silver nanoparticles were evaluated for their antimicrobial activity against several bacterial species and various bacterial strains within the same species. The cationic silver nanoparticles were found to be more effective against Pseudomonas aeruginosa 3 compared to other bacterial species/strains investigated. Some of the bacterial strains of the same species showed variable antibacterial activity. The difference in antimicrobial activity of these particles has led to the conclusion that antimicrobial products formed from silver nanoparticles may not be equally effective against all the bacteria. This difference in the antibacterial activity of silver nanoparticles for different bacterial strains from the same species may be due to the genome islands that are acquired through horizontal gene transfer (HGT). These genome islands are expected to possess some genes that may encode enzymes to resist the antimicrobial activity of silver nanoparticles. These silver nanoparticles may thus also be used to differentiate some bacterial strains within the same species due to variable silver resistance of these variants, which may not possible by simple biochemical tests. Springer 2014-10-11 /pmc/articles/PMC4242785/ /pubmed/25435831 http://dx.doi.org/10.1186/1556-276X-9-565 Text en Copyright © 2014 Ashraf et al.; licensee Springer. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Nano Express
Ashraf, Sumaira
Chatha, Mariyam Asghar
Ejaz, Wardah
Janjua, Hussnain Ahmed
Hussain, Irshad
Lysozyme-coated silver nanoparticles for differentiating bacterial strains on the basis of antibacterial activity
title Lysozyme-coated silver nanoparticles for differentiating bacterial strains on the basis of antibacterial activity
title_full Lysozyme-coated silver nanoparticles for differentiating bacterial strains on the basis of antibacterial activity
title_fullStr Lysozyme-coated silver nanoparticles for differentiating bacterial strains on the basis of antibacterial activity
title_full_unstemmed Lysozyme-coated silver nanoparticles for differentiating bacterial strains on the basis of antibacterial activity
title_short Lysozyme-coated silver nanoparticles for differentiating bacterial strains on the basis of antibacterial activity
title_sort lysozyme-coated silver nanoparticles for differentiating bacterial strains on the basis of antibacterial activity
topic Nano Express
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242785/
https://www.ncbi.nlm.nih.gov/pubmed/25435831
http://dx.doi.org/10.1186/1556-276X-9-565
work_keys_str_mv AT ashrafsumaira lysozymecoatedsilvernanoparticlesfordifferentiatingbacterialstrainsonthebasisofantibacterialactivity
AT chathamariyamasghar lysozymecoatedsilvernanoparticlesfordifferentiatingbacterialstrainsonthebasisofantibacterialactivity
AT ejazwardah lysozymecoatedsilvernanoparticlesfordifferentiatingbacterialstrainsonthebasisofantibacterialactivity
AT janjuahussnainahmed lysozymecoatedsilvernanoparticlesfordifferentiatingbacterialstrainsonthebasisofantibacterialactivity
AT hussainirshad lysozymecoatedsilvernanoparticlesfordifferentiatingbacterialstrainsonthebasisofantibacterialactivity